ArticleFrontiers in oncology2026
Number of examined lymph nodes and overall survival in intrahepatic cholangiocarcinoma: a population-based study suggesting a staging benefit.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The prognostic role of lymph node yield (LNY) in intrahepatic cholangiocarcinoma (ICC) remains debated. We aimed to clarify the role of LNY by examining its association with nodal detection and overall survival (OS). Methods: We identified patients with surgically resected ICC (2004-2022) from the SEER database. Multivariable Cox models and inverse probability of treatment weighting (IPTW) stratified by nodal status were used to evaluate the association between LNY (≥6 vs <6) and OS. Logistic regression examined predictors of nodal metastasis. Results: LNY ≥6 was not independently associated with OS (HR 0.88, 95% CI 0.71-1.08; P = 0.209). Nodal metastasis (HR 2.29), advanced T category, larger tumor size, poor differentiation, male sex, and lack of chemotherapy were independently associated with worse OS. Notably, multiple tumors were associated with better OS than single tumors (HR 0.79), likely reflecting selection bias. After IPTW, LNY remained non-significant in both the N0 (HR 0.81, 95% CI 0.59-1.11) and N1 (HR 0.95, 95% CI 0.70-1.29) subgroups. Higher LNY was strongly associated with detecting nodal metastasis (OR 4.06, 95% CI 2.99-5.52; P < 0.001). Conclusions: These findings suggest that nodal evaluation in resected ICC primarily improves staging accuracy, and are compatible with-though not directly confirmatory of-the stage-migration hypothesis. Adequate nodal assessment remains important for accurate prognostication, although a modest therapeutic effect of lymphadenectomy cannot be entirely excluded.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.